Electrocochleography and gentamicin therapy for Meniere's disease: A preliminary report

American Journal of Otology

Volumn 21, Issue 4, 2000, Pages 534-542

  Adamonis, J ^a   Stanton, S G ^b   Cashman, M Z ^a   Mattan, K ^a   Nedzelski, J M ^a   Chen, J M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Auditory evoked potentials; Electrocochleography; Gentamicin; Meniere's disease

Indexed keywords

GENTAMICIN;

ARTICLE; AUDIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCOCHLEOGRAPHY; EVOKED AUDITORY RESPONSE; HUMAN; IMPEDANCE; LONGITUDINAL STUDY; MENIERE DISEASE; NERVE POTENTIAL; PRIORITY JOURNAL;

ACOUSTIC IMPEDANCE TESTS; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; AUDIOMETRY; AUDIOMETRY, EVOKED RESPONSE; CASE-CONTROL STUDIES; COCHLEAR MICROPHONIC POTENTIALS; DRUG MONITORING; GENTAMICINS; HUMANS; MENIERE'S DISEASE; PROSPECTIVE STUDIES; REACTION TIME; SEVERITY OF ILLNESS INDEX;

EID: 0033932482     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Gulya AJ, Schuknecht HF. Classification of endolymphatic hydrops. Am J Otolaryngol 1982;3:319-22.
2. Schuknecht HF, Gulya AJ. Endolymphatic hydrops: an overview and classification. Ann Otol Rhinol Laryngol 1983;92:1-20.
3. Meniere P. Pathologie auriculaire: memoires sur de lesions de l' oreille interne donnant lieu a' des symptomes de congestion cerebrale apoplectiforme. Gaz Med Paris 1861;16:597-601.
4. Eggermont JJ. Summating potentials in Ménière's disease. Arch Otorhinolaryngol 1979;222:63-75.
5. Daumann R, Aran JM, de Sauvage RC, et al. Clinical significance of the summating potential in Ménière's disease. Am J Otol 1988; 9:31-8.
6. Durrant JD, Dallos P. Modification of DIF summating potential components by stimulus biasing. J Acoust Soc Am 1974;56:562-70.
7. Klockhoff I, Lindblom U. Endolymphatic hydrops revealed by glycerol test: preliminary report. Acta Otolaryngol 1966;61:459-62.
8. Goin DW, Staller SJ, Asher DL, Mitschke RE. Summating potential in Ménière's disease. Laryngoscope 1982;92:1383-9.
9. Kimura RS. Distribution, structure and function of the dark cells in the vestibular labyrinth. Ann Otol Rhinol Laryngol 1969;78:542-61.
10. Pender JD. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 1985;6:359-67.
11. Nakai Y, Hilding YD. Vestibular endolymph-producing epithelium: electron microscopic study of the development and histochemistry of the dark cells of the crista ampullaris. Acta Otolaryngol (Stockh) 1968;66:369-85.
12. Sparwald E, Lange G, Leuke M. Veranderungen an den dunklen Zellen der Crista ampullaris nach Streptomycinintoxikation beim Meerschweinchen. Arch Klin Exp Ohr Nas U Kehlk Heilk 1971; 199:587-90.
13. Sparwald E. Merk W, Leupe M. Restitutionsvorgange an den dunklen Zellen und Sinneszellen der Crista ampullaris des Meerschweinchens nach Streptomycinintoxikation. Arch Klin Ohr Nas U Kehlk Heilk 1973;202:687-9.
14. Beck C. Intratympanic application of gentamicin for treatment of Ménière's disease. Keio J Med 1986;35:36-41.
15. Lange G. Gentamicin and other ototoxic antibiotics for the transtympanic treatment for Ménière's disease. Arch Otorhinolaryngol 1989;246:269-70.
16. Schuknecht HF. Ablation therapy in the management of Ménière's disease. Acta Otolaryngol (Suppl) (Stockh) 1957;132:1-42.
17. Beck C, Schmidt CL. Ten years experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Ménière. Arch Otorhinolaryngol 1978;221:149-52.
18. Yamazaki T, Hayashi M, Kozaki H. Intratympanic gentamicin therapy for Ménière's disease placed by tubal catheter with systemic isosorbide. Arch Otolaryngol Head Neck Surg 1988;245: 170-4.
19. Lange G. Transtympanic treatment for Meniere's disease with gentamicin sulfate. In: Vosteen K-H, Schuknecht H, Pfaltz CR, Wersall J, Kimura RS, Juhn SK, eds. Meniere's Disease: Pathogenesis, Diagnosis and Treatment. International Symposium, Dusseldorf, May 1990. New York: Thieme Stratton, 1981:208-11.
20. Odkvist LM. Middle ear ototoxic treatment of inner ear disease. Acta Otolaryngol (Suppl) (Stockh) 1988;457:83-6.
21. Moller C, Odkvist LM, Thell J, et al. Vestibular and audiologic functions in gentamicin treated Ménière's disease. Am J Otol 1988; 9:383-91.
22. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Ménière's disease: rationale for extremely low dose therapy. Acta Otolaryngol 1991;111:671-6.
23. Nedzelski JM, Bryce GE, Pfleiderer AG. Treatment of Ménière's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992;21:95-101.
24. Nedzelski JM, Schessel DA, Bryce GE, et al. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Ménière's disease. Am J Otol 1992;13:18-22.
25. Nedzelski JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: update of an ongoing study. Am J Otol 1993;14:278-82.
26. Lilly DJ, Black FO. Electrocochleography in the diagnosis of Ménière's disease. In: Nadol JB, ed. Ménière's Disease. Berkeley, Kugler and Ghedini, 1989:369-73.
27. Ruth RA, Lambert PR, Ferraro JA. Electrocochleography: methods and clinical applications. Am J Otol 1988;9(Suppl):1-11.
28. Ferraro JA. Electrocochleography: how - part I. Audiology Today 1992;4:26-28.
29. Margolis RH, Rieks D, Fournier EM, et al. Tympanic electrocochleography for diagnosis of Ménière's disease. Arch Otolaryngol Head Neck Surg 1995;121:44-55.
30. Margolis RH, Levine SC, Fournier EM, et al. Tympanic electrocochleography: normal and abnormal patterns of response. Audiology 1992;31:8-24.
31. Mori N, Asai H, Doi K, et al. Diagnostic value of extratympanic electrocochleography in Ménière's disease. Audiology 1987;26: 103-10.
32. Gibson WPR, Prasher DK. Electrocochleography and its role in the diagnosis and understanding of Ménière's disease. Otol Clin North Am 1983;16:59-68.
33. Ferraro JA, Arenberg IK, Hassanein RS. Electrocochleography and symptoms of inner ear disfunction. Arch Otolaryngol 1985;111:1-74.
34. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55.
35. Trine MB, Lynn SG, Facer GW, Kasperbauer JL. Intratympanic gentamicin treatment: preliminary results in two patients with Ménière's disease. J Am Acad Audiol 1995;6:264-70.
36. Hawkins Jr JE. Ototoxic mechanisms: a working hypothesis. Audiology 1973;12:383-93.
37. Johnsson LG, Hawkins JE. Strial atrophy in clinical and experimental deafness. Laryngoscope 1972;82:1105-25.
38. Schacht J. Biochemistry of neomycin ototoxicity. JASA 1976;59: 940-4.
39. Dulon D, Aurousseau C, Erre JP, Aran JM. Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the guinea pig. Acta Otolaryngol (Stockh) 1988;106:219-25.
40. Hiel H, Bennani H, Erre JP, Aurousseau C, Aran JM. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol (Stockh) 1992;112:272-7.
41. Hiel H, Erre JP, Aurousseau, Bouali R, Dulon D, Aran JM. Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment. Audiology 1993;32:78-87.
42. Hawkins Jr JE, Johnsson LG, Aran JM. Comparative test of gentamicin ototoxicity. J Infect Dis 1969;119:417-26.
43. Tange RA, Conijn EA, van Zeijl LG, Huizing EH. Pattern of gentamicin-induced cochlear degeneration in the guinea pig. Arch Otol Rhinol Laryngol 1982;36:173-84.
44. Arenberg IK, Kobayashi H, Obert AD, et al. Intraoperative electrocochleography of endolymphatic hydrops surgery using clicks and tone bursts. Acta Otolaryntol (Stockh) 1993;(Suppl 504):58-67.
45. Orchik DJ, Shea JJ, Ge NN. Summating potential and action potential ratio in Ménière's disease before and after treatment. Am J Otol 1998;19:478-83.
46. Moffat D, Gibson W, Ramsden R. Transtympanic electrocochleography during glycerol dehydration. Acta Otolaryngol 1978;85: 158-66.
47. Moffat DA. Transtympanic electrocochleography in Ménière's disease: variation in the amplitude of the summating potential related to clinical status. Br J Audiol 1979;13:149-52.
48. Coats AC, Alford BR. Ménière's disease and the summating potential: III. Effect of glycerol administration. Arch Otolaryngol 1981;107:469-73.
49. Yellin MW, Waller M, Roland P. Dehydration testing and diagnosis of Ménière's disease: case report. J Am Acad Audiol 1993; 4:432-6.
50. Whitaker SR. Sequential electrocochleography and auditory dehydration testing in patients with Ménière's disease. Sem Hear 1986; 7:329-37.
51. Monsell EM. Electrocochleographic recordings in patients undergoing labrinthotomy with streptomycin infusion. In: Arenberg IK, ed. Surgery of the Inner Ear. Proceedings of the Third International Symposium and Workshops on the Surgery of the Inner Ear. Snowmass, Colorado, July 29-August 4, 1990. Amsterdam/New York: Kugler Publications, 1991:233-6.
52. Koyuncu M, Mason SM, Shinkwin C. Effect of hearing loss in electrocochleographic investigation of endolymphatic hydrops using tone-pip and click stimuli. J Laryngol Otol 1994;108:125-30.
53. Dauman R, Aran JM, Portmann M. Summating potential and water balance in Ménière's disease. Ann Otol Rhinol Laryngol 1986;95: 389-95.
54. Aso S, Watanabe Y, Mizukoshi K. A clinical study of electrocochleography in Ménière's disease. Acta Otolaryngol (Stockh) 1991;111:44-52.
55. Paparella MM. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Ménière's disease and its symptoms (mechanical and chemical). Acta Otolaryngol 1985; 99:445-51.
56. Tran Ba Huy P. Electrophysiological and biochemical findings in four cases of Ménière's disease. Acta Otolaryngol 1984;97:571-9.
57. Orchik DJ, Ge NN, Shea JJ. Action potential latency shift by rarefaction and condensation clicks in Ménière's disease. J Am Acad Audiol 1998;9:121-6.
58. Yoshie N, Ohashi T, Suzuki T: Non-surgical recording of auditory nerve action potentials in man. Laryngoscope 1967;77:76-85.